Jaehak Oh

Jaehak Oh is an accomplished scientific leader with a Ph.D. in Immunology and a robust background in managing innovative immune-oncology projects. They have held positions at institutions such as the University of California, San Francisco, and Genentech, where they contributed significantly to advancements in cancer immunology. Currently serving as a Senior Scientist at Amgen, Jaehak oversees immune-oncology projects while pioneering novel immunotherapies targeting myeloid cells. Their prolific contributions include first-author publications, invited presentations, and patent applications, reflecting a deep commitment to scientific excellence.